Fingerprint
Dive into the research topics of 'Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes
Eric Simpson, April Armstrong, Mark Boguniewicz, Zelma C. Chiesa Fuxench, Meghan Feely, Evangeline Pierce, Luna Sun, Yun Fei Chen, Robinette Angle, Jonathan I. Silverberg
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations